ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

To Industry for Development, NDA

November 18, 1977

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006